CG
MBIO icon

CFO4Life Group’s Mustang Bio MBIO Stock Holding History

CFO4Life Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9K Buy
20,461
+7,500
+58% +$7.06K ﹤0.01% 208
2025
Q4 		$12.7K Buy
12,961
+2,500
+24% +$3.3K ﹤0.01% 240
2025
Q3 		$15.9K Buy
+10,461
New +$18.6K ﹤0.01% 233

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

CFO4Life Group's MBIO Position: Q1 2026 in Review

CFO4Life Group increased its Mustang Bio (MBIO) stake by 58% in Q1 2026, buying an estimated $7.06K and bringing the position to 20,461 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #208.

CFO4Life Group first reported a position in MBIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $15.9K in Q3 2025. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • CFO4Life Group held 20,461 shares of Mustang Bio worth $14.9K as of Q1 2026.
  • CFO4Life Group bought 7,500 Mustang Bio shares in Q1 2026, an estimated $7.06K.
  • Mustang Bio made up ﹤0.01% of CFO4Life Group's portfolio in Q1 2026, its #208 holding.
  • CFO4Life Group first reported a position in Mustang Bio in Q3 2025 and has held it in 3 quarters since.
  • CFO4Life Group's Mustang Bio position peaked at $15.9K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.